Compound ID | 690
Synonym(s): XOMA-629
Class: Antimicrobial peptide
| Agent Type: | Natural product; Indirect acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Binds and neutralizes lipopolysaccharide and endotoxin to prevent the host's acute inflammatory response; endotoxin inhibitor; endotoxin antagonist |
| Target Pathogen: | Active against Staphylococcus aureus and Pseudomonas aeruginosa |
| Description: | A bactericidal permeability-increasing protein; a cationic alpha-helical peptide |
| Institute where first reported: | XOMA Corp., US |
| Year first mentioned: | 2001 |
| Highest development stage: | Phase 3 |
| Development status: | Inactive |
| Reason dropped: | Failed to show efficacy |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9877039 |
| Guide to Pharmacology: | XMP-629 |
| Citation: | https://doi.org/10.1038/nrmicro2745 |